Tesla's mid-size SUV, the Model Y, is a sales juggernaut. It is sold on the same platform all over the world, which makes it one of the best-selling cars globally. It comes in three versions: Standard ...

An upcoming Yellowstone spinoff titled Y: Marshals has finally set a premiere date, and it's going to anchor Sunday nights for CBS beginning in March. The new show sees ex-Yellowstone star Luke Grimes ...

The Tesla Model Y Standard's fabric-covered glass roof has stirred up controversy. People are saying it's a case of decontenting gone too far. Lars Moravy, Tesla's top engineer, took to X to explain ...

Evan Williams is an automotive journalist and mechanical engineering technologist with more than a decade of experience in the industry. He has written for the Toronto Star and AutoTrader Canada and ...

For all of Elon Musk’s grand promises over the past couple of years about game-changing budget Teslas, the much-touted affordable models have arrived with more of a polite cough than a thunderclap. As ...

The One Big, Beautiful Bill Act is bringing the EV tax credit to a swift end this September. Consumers can save thousands on a brand-new Tesla Model Y by using this incentive. Critics and experts are ...

The flagship variant will sit at the top of the Model Y line-up, priced at around $96,000 drive-away. This places it significantly above the Long Range AWD Model Y ($74,620 drive-away) and the ...

CBS' Yellowstone spinoff Y: Marshals has rounded out its ensemble cast, which now includes several familiar faces from the original Paramount Network series, TVLine has learned. Let's start with who's ...

(Clockwise from left) Gil Birmingham, Brecken Merrill, Mo Brings Plenty, Arielle Kebbel, Ash Santos, Brett Cullen and Tatanka Means Courtesy Yellowstone spinoff series Y: Marshals has rounded out the ...

The Model Y offers the same entertainment functions as the Model 3, including embedded Netflix, Hulu, and YouTube apps, as well as video games, all perfect for killing time while waiting for the ...

After Y-mAbs Therapeutics won its first FDA approval more than four years ago, the company has faced numerous hurdles on its quest to become an oncology powerhouse. Now, the drugmaker is moving to ...